
Ncardia @ Neuroscience 2023: Insights & Scientific Advances

Ncardia @ ESGCT: Highlights from our week in Brussels

Press release: Ncardia And Cellistic Recruit Charles Jacques as new Chief Financial Officer

Advancing Gene Therapies: FDA's Milestone Approval for Duchenne Muscular Dystrophy Treatment

The Rise of iPSCs in Drug Discovery: Regulatory and Legislative Changes Driving the Shift from Animal Models

FDA Modernization Act 2.0: FDA no longer requires all drugs to be tested on animals before human trials